New York State Common Retirement Fund’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

New York State Common Retirement Fund’s Portfolio HTGM Stock Details HTGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-203	Closed	-$61K	–	3250
2019 Q2	$61K	Sell	203 -17	-8%	-$7.09K	﹤0.01%	3188
2019 Q1	$99K	Sell	220 -29	-12%	-$12.7K	﹤0.01%	2957
2018 Q4	$114K	Sell	249 -10	-4%	-$6.2K	﹤0.01%	2924
2018 Q3	$236K	Hold	259	–	–	﹤0.01%	2754
2018 Q2	$152K	Sell	259 -2	-0.8%	-$1.3K	﹤0.01%	2996
2018 Q1	$170K	Buy	+261	New	+$196K	﹤0.01%	2800

Other funds holding HTGM

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

New York State Common Retirement Fund's HTGM Position: Q3 2019 in Review

New York State Common Retirement Fund sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q3 2019, closing a stake of 203 shares — an estimated $61K sold.

New York State Common Retirement Fund first reported a position in HTGM in Q1 2018 and held it in 6 quarters. The position peaked at $236K in Q3 2018. 44 funds tracked by Wall St. Rank hold HTGM as of Q3 2019.

New York State Common Retirement Fund reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
New York State Common Retirement Fund sold 203 HTG Molecular Diagnostics, Inc. Common Stock shares in Q3 2019, an estimated $61K.
New York State Common Retirement Fund first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q1 2018 and held it in 6 quarters.
New York State Common Retirement Fund's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $236K in Q3 2018.
44 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q3 2019.

Based on New York State Common Retirement Fund's 13F filing for Q3 2019, filed 7 Nov 2019.